Solara Active Pharma Sciences posts Q4 FY25 consolidated loss at Rs. 2.10 Cr
News

Solara Active Pharma Sciences posts Q4 FY25 consolidated loss at Rs. 2.10 Cr

The company has posted net profit of Rs. 0.54 crores for the Financial Year ended March 31, 2025

  • By IPP Bureau | May 18, 2025

Solara Active Pharma Sciences Limited has reported consolidated financial results for the period ended March 31, 2025.

Solara Active Pharma Sciences has posted net loss of Rs. 2.10 crores for the period ended March 31, 2025 as against net profit of Rs. 8.09 crores for the period ended December 31, 2024. The company posted net loss of Rs. 255.34 crores for the period ended March 31, 2024.

Solara Active Pharma Sciences has reported total income of Rs. 278.96 crores during the period ended March 31, 2025 as compared to Rs. 301.80 crores during the period ended December 31, 2024. The company reported total income of Rs. 301.13 crores during the period ended March 31, 2024.

For the Financial Year ended March 31, 2025, Solara Active Pharma Sciences has reported total income of Rs. 1,292.08 crores as compared to Rs. 1,294.29 crores during the Financial Year ended March 31, 2024.

The company has posted net profit of Rs. 0.54 crores for the Financial Year ended March 31, 2025 as against net loss of Rs. 567.39 crores for the Financial Year ended March 31, 2024.

Upcoming E-conference

Other Related stories

Startup

Digitization